Liquidia Technologies (LQDA) Research Coverage Started at Jefferies Financial Group

Share on StockTwits

Analysts at Jefferies Financial Group began coverage on shares of Liquidia Technologies (NASDAQ:LQDA) in a research note issued to investors on Thursday, Marketbeat reports. The brokerage set a “buy” rating and a $27.00 price target on the stock. Jefferies Financial Group’s target price suggests a potential upside of 41.51% from the stock’s current price.

LQDA has been the topic of a number of other research reports. Needham & Company LLC began coverage on shares of Liquidia Technologies in a research report on Monday, August 20th. They issued a “buy” rating and a $30.00 price objective on the stock. Cowen set a $40.00 target price on shares of Liquidia Technologies and gave the stock a “buy” rating in a research report on Wednesday, October 31st. Wedbush initiated coverage on shares of Liquidia Technologies in a research report on Tuesday, September 4th. They set an “outperform” rating and a $26.00 target price on the stock. Finally, Zacks Investment Research downgraded shares of Liquidia Technologies from a “hold” rating to a “sell” rating in a research report on Wednesday. One equities research analyst has rated the stock with a sell rating and four have given a buy rating to the company’s stock. Liquidia Technologies has a consensus rating of “Buy” and an average price target of $31.75.

Shares of Liquidia Technologies stock traded up $0.85 on Thursday, reaching $19.08. The stock had a trading volume of 24,759 shares, compared to its average volume of 52,688. The company has a quick ratio of 6.27, a current ratio of 6.27 and a debt-to-equity ratio of 0.40. Liquidia Technologies has a 1 year low of $10.52 and a 1 year high of $38.46.

Liquidia Technologies (NASDAQ:LQDA) last issued its quarterly earnings data on Wednesday, October 31st. The company reported ($0.83) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.57) by ($0.26). The firm had revenue of $0.17 million for the quarter, compared to analysts’ expectations of $1.03 million. On average, equities research analysts forecast that Liquidia Technologies will post -5.44 EPS for the current fiscal year.

A number of large investors have recently added to or reduced their stakes in the business. FMR LLC purchased a new stake in Liquidia Technologies during the 3rd quarter worth approximately $6,729,000. BlackRock Inc. purchased a new stake in Liquidia Technologies during the 3rd quarter worth approximately $5,924,000. Finally, Dean Capital Investments Management LLC purchased a new stake in Liquidia Technologies during the 3rd quarter worth approximately $1,483,000. 0.01% of the stock is currently owned by institutional investors.

About Liquidia Technologies

Liquidia Technologies, Inc is a late-stage clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. PRINT technology is a particle engineering platform that enables precise production of uniform drug particles designed to improve the safety, efficacy and performance of a wide range of therapies.

Recommended Story: Buyback For Investors Defined

Receive News & Ratings for Liquidia Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liquidia Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.